🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 5 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/03/2000 | 53,32 | 54,15 | 52,84 | 53,91 | -0,88% | 2,46% | 7.484.082 |
| 13/03/2000 | 53,79 | 55,05 | 53,55 | 54,39 | -4,30% | 2,77% | 9.302.991 |
| 10/03/2000 | 58,92 | 59,04 | 56,30 | 56,83 | -2,56% | 4,66% | 8.712.967 |
| 09/03/2000 | 55,82 | 58,80 | 55,05 | 58,33 | +7,59% | 6,73% | 12.869.650 |
| 08/03/2000 | 51,47 | 54,81 | 51,47 | 54,21 | +5,33% | 6,49% | 12.569.712 |
| 07/03/2000 | 53,44 | 53,44 | 49,62 | 51,47 | -4,54% | 7,14% | 13.544.142 |
| 06/03/2000 | 54,81 | 55,11 | 53,67 | 53,91 | -1,74% | 2,61% | 9.103.138 |
| 03/03/2000 | 57,31 | 57,37 | 54,45 | 54,87 | -2,95% | 5,10% | 10.706.892 |
| 02/03/2000 | 57,31 | 57,97 | 56,54 | 56,54 | -1,25% | 2,50% | 6.167.061 |
| 01/03/2000 | 58,68 | 58,92 | 57,01 | 57,25 | -2,54% | 3,25% | 7.289.574 |
| 29/02/2000 | 59,58 | 60,23 | 58,56 | 58,74 | +0,00% | 2,80% | 8.243.778 |
| 28/02/2000 | 57,43 | 59,10 | 57,25 | 58,74 | +2,28% | 3,22% | 8.895.634 |
| 25/02/2000 | 58,27 | 58,68 | 56,48 | 57,43 | -2,92% | 3,79% | 8.070.962 |
| 24/02/2000 | 60,41 | 60,41 | 57,91 | 59,16 | -1,78% | 4,15% | 9.502.006 |
| 23/02/2000 | 62,98 | 62,98 | 60,23 | 60,23 | -3,63% | 4,36% | 8.099.468 |
| 22/02/2000 | 59,64 | 62,50 | 58,98 | 62,50 | +5,65% | 5,90% | 9.640.971 |
| 18/02/2000 | 60,53 | 61,43 | 58,74 | 59,16 | -1,98% | 4,43% | 6.934.721 |
| 17/02/2000 | 63,33 | 63,63 | 60,23 | 60,35 | -3,44% | 5,37% | 7.269.871 |
| 16/02/2000 | 62,50 | 64,11 | 62,26 | 62,50 | -0,19% | 2,96% | 5.383.995 |
| 15/02/2000 | 62,74 | 63,57 | 62,14 | 62,62 | -0,66% | 2,28% | 6.683.201 |
| 14/02/2000 | 62,50 | 63,39 | 61,07 | 63,04 | +1,25% | 3,72% | 9.361.889 |
| 11/02/2000 | 64,53 | 65,00 | 61,37 | 62,26 | -5,43% | 5,64% | 9.655.643 |
| 10/02/2000 | 66,79 | 67,03 | 64,89 | 65,84 | -3,33% | 3,21% | 7.356.436 |
| 09/02/2000 | 70,73 | 70,79 | 67,63 | 68,11 | -5,39% | 4,47% | 7.259.810 |
| 08/02/2000 | 72,04 | 72,40 | 71,62 | 71,98 | +0,25% | 1,08% | 4.128.282 |
| 07/02/2000 | 70,85 | 71,98 | 70,37 | 71,80 | +0,25% | 2,27% | 4.370.370 |
| 04/02/2000 | 73,35 | 73,35 | 71,51 | 71,62 | -1,56% | 2,52% | 4.466.681 |
| 03/02/2000 | 72,82 | 73,18 | 71,92 | 72,76 | -0,81% | 1,72% | 4.059.952 |
| 02/02/2000 | 73,77 | 74,79 | 72,46 | 73,35 | +0,08% | 3,15% | 4.865.550 |
| 01/02/2000 | 73,83 | 74,37 | 72,04 | 73,29 | -2,31% | 3,15% | 5.267.667 |